European Committee for Treatment & Research in Multiple Sclerosis

European Committee for Treatment & Research in Multiple Sclerosis The European Committee for Treatment & Research in Multiple Sclerosis - the world's largest organisat

SAVE THE DATE: MSMilan2023, the 9th joint ECTRIMS-ACTRIMS meeting, will be held as a hybrid event on 11–13 October in Milan, Italy

🎙️“The encouraging part is that there is a role for the microbiome, which we can harness to improve disease or to predic...
14/01/2026

🎙️“The encouraging part is that there is a role for the microbiome, which we can harness to improve disease or to predict disease.” — Dr. Mahesh Desai

In our latest podcast episode, host Brett Drummond speaks with Dr. Mahesh Desai from Luxembourg Institute of Health and Dr. Ashutosh Mangalam from University of Iowa about the growing evidence that the gut microbiome plays a meaningful role in multiple sclerosis — influencing immune regulation, disease susceptibility, and progression.

The conversation highlights why translating microbiome research into clinical insight remains complex, and why simplistic ideas of “good” and “bad” bacteria often fall short. Together, they explore microbial function, host–microbiome dialogue, and why diet and personalised approaches may be central to future MS interventions.

🎧 Listen to the episode now:

Spotify ▶️ https://bit.ly/49R3sam
Apple ▶️ https://apple.co/49SE97G
Website ▶️ https://bit.ly/4jJj2Z8

MStranslate

⏳ Only 2 weeks left to catch up on  !If you missed any sessions, now is the time to explore the Congress content on dema...
13/01/2026

⏳ Only 2 weeks left to catch up on !

If you missed any sessions, now is the time to explore the Congress content on demand. More than 100 scientific sessions are available to watch until 31 January 2026.

📽️Rewatch the ECTRIMS Lecture: Cognitive Function in MS: Progress and Perspectives

Watch the replay here 👉https://ectrims-congress.virtual-meeting.org/programme/session/67874

Maria Pia Amato of Università degli Studi di Firenze explored how big data, AI, digital technologies, remote monitoring, and biomarkers are transforming MS research and care, and the way we understand and manage cognitive challenges.

🌍 Discover myECTRIMS — your global hub for everything ECTRIMSLooking for easy access to all things ECTRIMS? myECTRIMS is...
12/01/2026

🌍 Discover myECTRIMS — your global hub for everything ECTRIMS

Looking for easy access to all things ECTRIMS? myECTRIMS is your personalised space to explore and manage your ECTRIMS experience.

✔️ Access your documents anytime
✔️ Browse abstracts, webcasts, ePosters, and presentations from past ECTRIMS Congresses
✔️ Enjoy a tailored experience, all in one place

👉 Log in today and explore: https://my.ectrims.eu/

09/01/2026

Living with multiple sclerosis means navigating a lot of information — and you don’t have to do it alone 💙

Sign up to our Patient Community newsletter to receive:
• easy-to-digest updates on the latest MS research
• information about upcoming Patient Day events
• practical insights you can use in everyday life
• news from MS organisations and regional partners around the world

👉 Subscribe here: https://bit.ly/4jv47Bv

09/01/2026

Living with multiple sclerosis means navigating a lot of information — and you don’t have to do it alone 💙

Sign up to our Patient Community newsletter to receive:

• Easy-to-digest updates on the latest MS research
• Information about upcoming events for people living with MS and related conditions
• Practical insights you can use in everyday life
• News from MS organisations and regional partners around the world

Stay informed. Stay connected. Be part of our global MS community.

👉 Subscribe here: https://bit.ly/4jv47Bv

Since 2022, Patient Community Day has grown from a modest beginning into a global legacy initiative uniting thousands of...
08/01/2026

Since 2022, Patient Community Day has grown from a modest beginning into a global legacy initiative uniting thousands of people living with MS, NMOSD, and MOGAD with the scientific community that serves them.

Our PCD 2025 Impact Report highlights an exceptional year of global connection, scientific exchange, and shared learning. This year, 2,383 people living with MS, NMOSD, and MOGAD from 89 countries joined us online and in Barcelona to learn, ask questions, and share their lived experience.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐏𝐂𝐃 𝐈𝐦𝐩𝐚𝐜𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫:
• Key scientific insights presented by world-leading experts
• Perspectives from our first People with Lived Experience Panel
• Interviews with patient advocacy leaders, clinicians, researchers, and people living with MS, NMOSD, and MOGAD

🌍 Explore the report and discover how Patient Community Day is shaping the future of MS research, treatment, and care: https://www.ectrimspatientcommunity.eu/impact-report/

📊 Looking to strengthen your statistical skills in MS research? Apply to the ECTRIMS Summer School 2026.The 11th ECTRIMS...
07/01/2026

📊 Looking to strengthen your statistical skills in MS research? Apply to the ECTRIMS Summer School 2026.

The 11th ECTRIMS Summer School on Statistical Techniques & Tools in MS Research will be held in Naples, Italy, from 8 to 10 June 2026.

📝 Apply now via myECTRIMS 👉 https://my.ectrims.eu/school/summer
⏰ Application deadline: 19 January 2026, 23:59 CET

The programme is designed for early-career clinicians, researchers, and data scientists interested in applying statistical methods to MS research.

It provides a solid foundation in standard statistical techniques and tools, combining a theoretical component – covering core statistical concepts and study design – with a practical component focused on the application of statistical methods to MS datasets.

🎥There are 3 weeks remaining to revisit the sessions from  . Rewatch one of the most inspiring moments!The 2025 Charcot ...
06/01/2026

🎥There are 3 weeks remaining to revisit the sessions from . Rewatch one of the most inspiring moments!

The 2025 Charcot Award celebrated Prof. Ludwig Kappos — a visionary leader whose decades of groundbreaking work have helped redefine MS diagnosis, treatment, and patient care worldwide.

From leading the MS Clinical Group at the Max Planck Society early in his career to shaping global research at the Universität Basel, Prof. Kappos has been instrumental in developing nearly every approved MS therapy over the past three decades. His contributions have revolutionised care, bringing safer, more effective, and more personalised treatment options to people living with MS.

🌟 Charcot Lecture: Developing MS Therapeutics – Success Factors and Call for Innovation

Key themes included:
• Clinical trials as a driver of therapeutic progress in MS
• Current and future challenges in MS care
• Emerging innovations for trials and daily practice

▶️ Watch the lecture replay: https://bit.ly/4q6pH1N

  | Beyond the CongressA new year brings new opportunities to grow our knowledge. The Best of Slide Decks is designed to...
05/01/2026

| Beyond the Congress

A new year brings new opportunities to grow our knowledge. The Best of Slide Decks is designed to support continuous learning and collaboration, featuring the most highly rated abstracts from Barcelona across multiple tracks, including RiMS - Rehabilitation in Multiple Sclerosis.
📥 Discover and share the highlights today on myECTRIMS ➡️ https://my.ectrims.eu/bestofslidedecks

📩 Stay connected with ECTRIMSSubscribe to the ECTRIMS newsletter to receive the latest updates on our congresses, educat...
02/01/2026

📩 Stay connected with ECTRIMS

Subscribe to the ECTRIMS newsletter to receive the latest updates on our congresses, educational opportunities, news, and key developments in MS research and clinical practice. Be among the first to hear about what’s coming next — delivered straight to your inbox and free to subscribe.

Subscribe today: https://bit.ly/4pgmkEp

💻 Looking for fresh perspectives in MS research, treatment, and care?Our webinars bring together leading voices to share...
01/01/2026

💻 Looking for fresh perspectives in MS research, treatment, and care?

Our webinars bring together leading voices to share insights, discuss emerging approaches, and inspire progress across the MS landscape. Sessions are available on demand—perfect if you missed one or want a deeper look.

Rewatch past sessions here: https://bit.ly/4j15Tdn

Catch up and be part of the conversation!

🎉 🔎 ECTRIMS Research Spotlight — Top 3 Spotlights of 2025With 16,000+ reads in 2025, ECTRIMS Spotlights have continued t...
31/12/2025

🎉 🔎 ECTRIMS Research Spotlight — Top 3 Spotlights of 2025

With 16,000+ reads in 2025, ECTRIMS Spotlights have continued to attract strong readership, reflecting growing interest in key advances across MS research.

To conclude our year-end countdown, we’re highlighting the article that ranked first among our most-read features.

1️⃣ Spotlight of the Year — Diagnosis of MS: 2024 Revisions of the McDonald Criteria

Read it here ➡️ https://ectrims.eu/insights/diagnosis-of-ms-2024-revisions-of-the-mcdonald-criteria/

Responding to widespread interest in the 2024 revisions of the McDonald Criteria, Jiwon Oh Medical Director of the Barlo MS Program at St. Michael's Hospital, University of Toronto and Tim Coetzee, Chief Executive of the National Multiple Sclerosis Society outlined the key updates and shed light on the global collaboration behind the scenes.

Written by our scientific content writer Stefania de Vito, this Spotlight concludes our year-end Top 3 series, highlighting the most-read and most impactful ECTRIMS features of 2025.

Adresse

Reinacherstrasse 131
Basel
4053

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Committee for Treatment & Research in Multiple Sclerosis erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an European Committee for Treatment & Research in Multiple Sclerosis senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram